Posts

Creative Biolabs Launches End-to-End AI-Driven Antibody Solutions to Accelerate Biotherapeutic Discovery and Engineering

on

RTW-backed startup Yarrow Bioscience signs autoimmune antibody deal with China’s GenSci

on

Novartis antibody ianalumab helps prolong control of rare blood disorder ITP

on

Cartography Biosciences Closes $67 Million Series B Round Led by Pfizer to Advance CRC T-cell Engager

on

Tourmaline Attracted Bidding War Before $1.4B Acquisition by Novartis

on

VectorY Strikes $1.2B Option and License Pact with Shape Therapeutics for Brain-Penetrant Gene Therapy Delivery

on

Lilly Opens AI Drug-Discovery Models to Biotechs for Free via TuneLab Platform

on

Novartis Acquires Tourmaline Bio for $1.4B to Bolster Cardiovascular Pipeline with Promising Phase 2 Drug

on

Novartis Pays $30M Upfront to Leqembi Creator BioArctic for Access to Blood-Brain Barrier Technology

on

Viridian Licenses Promising Eye Disease Candidates to Kissei for Japanese Market

on

Alphabet's Calico Strikes $596M Deal for Mabwell's Anti-Aging Antibody

on

Regeneron Secures EU Approval for Bispecific Antibody Lynozyfic, Positioning for Competition Against J&J and Pfizer

on

'Deviated from the core': Akeso CEO tries to reset expectations of bispecific's survival readout amid market tumult

on

German cancer antibody biotech eyes SPAC as route to Nasdaq

on

AstraZeneca, Daiichi say Enhertu delivers 'highly statistically significant' efficacy in first-line breast cancer

on

Stealth biotech bags rights to VelaVigo bispecific in $440M deal

on

Sanofi pens $1.8B research deal for 2 bispecific antibodies aimed at autoimmune, immunology

on

Isomorphic Labs Secures $600M to Accelerate AI-Powered Drug Discovery

on

Sanofi Expands Immunology Pipeline with $600M Acquisition of Dren Bio's Novel B-Cell Depleting Bispecific Antibody

on

ImmunoPrecise Antibodies Secures $8-10M Partnership for Novel Cancer Therapeutics Development

on